Papanicolaou Society of Cytopathology guidelines for educational notes, disclaimers, and similar comments on reports of cervical cytology specimens

Diagnostic Cytopathology

Volumn 28, Issue 5, 2003, Pages 282-285

  Layfield, Lester J ^a   Elsheikh, Tarik M ^b   Filie, Armando ^c   Nayar, Ritu ^d   Shidham, Vinod ^e  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b BALL MEMORIAL HOSPITAL   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Cervical cytology; Guidelines; Papanicolaou test

Indexed keywords

CLINICAL PRACTICE; HUMAN; MEDICAL EDUCATION; MEDICAL SOCIETY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CYTOLOGY;

DISCLOSURE; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MASS SCREENING; PATHOLOGY, CLINICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0038754998     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/dc.10284     Document Type: Review

References (10)

1. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. JAMA 1989;262:931-934.
2. The 1991 Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda Workshop. JAMA 1992;267: 1982.
3. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-2119.
4. Wright TC Jr, Cox JT, Massad LS, et al. 2001 ASCCP sponsored Consensus Conference. 2001 Consensus guidelines for the management of women with cervical cytologic abnormalities. JAMA 2002; 287:2120-2129.
5. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995;141:680-689.
6. Evaluation of Cervical Cytology. Agency for Health Care Policy and Research Publication No. 99-E101, February 1999.
7. Hutchinson ML, Zahniser DJ, Sherman ME, Herrero R, et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer (Cancer Cytopathol) 1999;87:48-55.
8. Janerich DT, Hadjimichael O, Schwartz P, et al. The screening histories of women with invasive cancer, Connecticut. Am J Public Health 1995;85:791-794.
9. Smith HO, Tiffany MF, Qualls CR, Key RC. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States: a 24-year population-based study. Gynecol Oncol 2000;78:97-105.
10. Mitchell H, Medley G, Gordon I, Giles G. Cervical cytology reported as negative and risk of adenocarcinoma of the cervix: no strong evidence of benefit. Br J Cancer 1995;71:894-897.